To gain further insights into how LRRK2 G2019S contributes to increased tumor promotion and progression, we conducted a comparative analysis of the inflammation and proliferation status in the colon tissues of LRRK2 KI mice and WT control mice during the early stage of tumorigenesis following AOM and DSS treatment (Figure 7A). The gene discussed is LRRK2; the disease is neoplasm.